Day One Biopharmaceuticals (DAWN) Named Best 2023 Stock Idea at Cowen
Tweet Send to a Friend
Cowen analyst Marc Frahm reiterated an Outperform rating on Day One Biopharmaceuticals (NASDAQ: DAWN) and named it a Best 2023 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
